1054. Activity of a Anti-staphylococcal Lysin, LSVT-1701: In vitro Susceptibility of Staphylococcus aureus and Coagulase-Negative Staphylococci (CoNS) Global Clinical Isolates (2002 to 2019)

BACKGROUND: LSVT-1701, formerly SAL200, is a novel, recombinantly-produced, bacteriophage-encoded lysin that specifically targets staphylococci via cell wall enzymatic hydrolysis. We reported the in vitro activity of LSVT-1701 against clinical isolates of S. aureus and coagulase-negative staphylococ...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, David, Sader, Helio S, Rhomberg, Paul R, Borroto-Esoda, Katyna, Gaukel, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644221/
http://dx.doi.org/10.1093/ofid/ofab466.1248

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644221/
http://dx.doi.org/10.1093/ofid/ofab466.1248

Ejemplares similares